Novel Dosage
Controlling the release of targeted drugs is a crucial step to successful therapy. Novel dosage forms including pre-filled syringes, cartridge/pen systems, transdermal patches, sub-lingual administration, and controlled release products are becoming available across different therapeutic targets. IPS experts rely on years of experience to design facilities that meet the challenges associated with production of novel drug delivery systems. Our team of experts use multidisciplinary approaches to ensure a flexible facility that will meet your future needs.
Featured Novel Dosage Experts
-
Jason S. Collins, AIA
Director of Process Architecture
-
Angus Dagnall
Director of Architecture EMEA
-
Brian J. Egan, RA, LEED AP
Director, Process Architecture
-
Sam Halaby
Sr. Director Global Strategy & Technology
-
Kevin Owen
Director of Aseptic Technologies - EMEA
-
Paul F. Valerio
Director, Process Technology
-
Michael Vileikis
Director, Process Technology